Cite
Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.
MLA
Hemida, Reda, et al. “Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.” Obstetrics and Gynecology, vol. 133, no. 5, May 2019, pp. 1024–31. EBSCOhost, https://doi.org/10.1097/AOG.0000000000003232.
APA
Hemida, R., Vos, E. L., El-Deek, B., Arafa, M., Toson, E., Burger, C. W., & van Doorn, H. C. (2019). Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial. Obstetrics and Gynecology, 133(5), 1024–1031. https://doi.org/10.1097/AOG.0000000000003232
Chicago
Hemida, Reda, Elvira L Vos, Basem El-Deek, Mohammad Arafa, Eman Toson, Curt W Burger, and Helena C van Doorn. 2019. “Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.” Obstetrics and Gynecology 133 (5): 1024–31. doi:10.1097/AOG.0000000000003232.